Norovirus

Scientists take step towards drug to treat norovirus stomach bug

21 Oct 2014

An experimental drug currently being trialled for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of Cambridge has shown that the drug, favipiravir, is effective at reducing – and in some cases eliminating – norovirus infection in mice.

Read More

Taking a shot at Parkinson’s

15 Oct 2014

Just one shot of dopamine cells derived from stem cells could be enough to reverse many of the features of Parkinson’s disease for decades – and the barriers to developing such a treatment are finally being overcome.

Read More

Stem cells: master builders, drug testers, immortal elements

01 Oct 2014

Today, we commence a month-long focus on research on stem cells. To begin, Professors Austin Smith and Robin Franklin discuss how Cambridge scientists are helping to provide a stream of new knowledge about how our bodies are made and maintained, and how stem cells can fulfil the promise of being one of medical research’s great hopes.

Read More

Body builders: collagen scaffolds

04 Jun 2014

Miniature scaffolds made from collagen – the ‘glue’ that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.

Read More

NICE approves MS drug developed by University of Cambridge researchers

28 May 2014

A new drug based on decades of research at the University of Cambridge has today been approved by the National Institute for Health and Care Excellence (NICE) for use in people with relapsing-remitting multiple sclerosis. Clinical trials have shown that Alemtuzumab, marketed under the name Lemtrada, reduces disease activity, limits the accumulation of further disability over time and may even allow some existing damage to recover.

Read More

Functional nerve cells from skin cells

22 May 2014

Research will make the study of diseases such as Parkinson’s and Alzheimer’s easier, and could lead to personalised therapies for a variety of neurodegenerative disorders.

Read More
Cell nucleus before and after treatment with Remodelin

'Remodelling' damaged nuclei could lead to new treatments for accelerated ageing disease

01 May 2014

Scientists at the University of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing.

Read More

Pages